Males exhibit higher incidence and worse prognosis for the majority of cancers, including glioblastoma (GBM). Disparate survival may be related to sex-biased responses to treatment, including radiation. Using a mouse model of GBM, we show that female cells are more sensitive to radiation, and that senescence represents a major component of the radiation therapeutic response in both sexes. Correlation analyses revealed that the CDK inhibitor p21 and irradiation induced senescence were differentially regulated between male and female cells. Indeed, female cellular senescence was more sensitive to changes in p21 levels, a finding that was observed in wildtype and transformed murine astrocytes, as well as patient-derived GBM cell lines. Using a...
The primary brain tumors, gliomas, are not very common but they are deadly. Each year in Sweden arou...
The molecular bases for sex differences in cancer remain undefined and how to incorporate them into ...
Introduction: Recent studies suggest an overrepresentation of MGMT promoter methylated tumors in fem...
Males exhibit higher incidence and worse prognosis for the majority of cancers, including glioblasto...
Mechanisms underlying sex differences in cancer incidence are not defined but likely involve dimorph...
The tumor suppressor TP53 (p53) is the most frequently mutated gene in cancer and among the most mut...
Many human diseases show sex differences in incidence, age of onset, and outcome, including autoimmu...
From the Washington University Office of Undergraduate Research Digest (WUURD), Vol. 13, 05-01-2018....
UNLABELLED: Sex differences in glioblastoma (GBM) incidence and outcome are well recognized, and eme...
The overall effect of senescence on cancer progression and cancer cell resistance to X-ray radiation...
International audienceAbstract Glioblastoma (GBM) is the most common primary malignant brain tumor i...
We now know that cancer is many different diseases, with great variation even within a single histol...
Sex differences in glioblastoma (GBM) incidence and outcome are well recognized, and emerging eviden...
BACKGROUND: Brain cancer incidence and mortality rates are greater in males. Understanding the molec...
Supplementary Fig. S1. Immune cell-dependent survival differences between males and females in murin...
The primary brain tumors, gliomas, are not very common but they are deadly. Each year in Sweden arou...
The molecular bases for sex differences in cancer remain undefined and how to incorporate them into ...
Introduction: Recent studies suggest an overrepresentation of MGMT promoter methylated tumors in fem...
Males exhibit higher incidence and worse prognosis for the majority of cancers, including glioblasto...
Mechanisms underlying sex differences in cancer incidence are not defined but likely involve dimorph...
The tumor suppressor TP53 (p53) is the most frequently mutated gene in cancer and among the most mut...
Many human diseases show sex differences in incidence, age of onset, and outcome, including autoimmu...
From the Washington University Office of Undergraduate Research Digest (WUURD), Vol. 13, 05-01-2018....
UNLABELLED: Sex differences in glioblastoma (GBM) incidence and outcome are well recognized, and eme...
The overall effect of senescence on cancer progression and cancer cell resistance to X-ray radiation...
International audienceAbstract Glioblastoma (GBM) is the most common primary malignant brain tumor i...
We now know that cancer is many different diseases, with great variation even within a single histol...
Sex differences in glioblastoma (GBM) incidence and outcome are well recognized, and emerging eviden...
BACKGROUND: Brain cancer incidence and mortality rates are greater in males. Understanding the molec...
Supplementary Fig. S1. Immune cell-dependent survival differences between males and females in murin...
The primary brain tumors, gliomas, are not very common but they are deadly. Each year in Sweden arou...
The molecular bases for sex differences in cancer remain undefined and how to incorporate them into ...
Introduction: Recent studies suggest an overrepresentation of MGMT promoter methylated tumors in fem...